Cannabis export testing requirements change with the destination, and a batch that clears Canadian release testing can still be turned away at the importer's gate. Canada sets the production floor. Germany applies the European Pharmacopoeia monograph plus a Qualified Person release. Australia applies TGO 93. Israel applies IMC-GMP. One release specification has to satisfy all four.
For a Canadian Licensed Producer, the useful question is rarely whether a batch passed. It's whose specification it passed against, by which method, reported in which units. What follows is the analytical requirement map for Canada, Germany, Australia and Israel as it stands in mid 2026, plus the documentation traps that most often park a shipment in quarantine.
Cannabis export testing requirements at a glance
Every regulated market you ship into tests the same six families of attributes. What differs is the numeric limit, the prescribed method, and who is legally answerable for the result.
- Cannabinoid identity and assay
- Microbial contamination
- Mycotoxins (aflatoxins and ochratoxin A)
- Heavy metals
- Pesticide residues
- Physical purity: foreign matter, loss on drying, total ash
| Test family | Canada | Germany and the EU | Australia |
|---|---|---|---|
| Cannabinoid assay | THC and CBD concentration reported per lot | Assay per the Ph. Eur. cannabis flower monograph | 80% to 120% of stated content for herbal final form |
| Microbial | Contaminant limits under section 94 of the Cannabis Regulations | Ph. Eur. herbal drug microbial limits | Microbiological standard for non-sterile medicines |
| Mycotoxins | Usually buyer specified | Ph. Eur. aflatoxin and ochratoxin A limits | Aflatoxin B1 max 2 ug/kg, total aflatoxins max 4 ug/kg, ochratoxin A max 20 ug/kg |
| Heavy metals | Contaminant limits under section 94 | Limits added by the current monograph | As 3.0, Cd 0.5, Pb 5.0, Hg 0.5 mg/kg |
| Pesticides | Mandatory list and limits published by Health Canada | Ph. Eur. 2.8.13 | Ph. Eur. 2.8.13 limits |
| Physical purity | Buyer specified | Foreign matter with no seeds, loss on drying max 12% | Foreign matter max 2.0%, total ash max 20.0% |
Where the table says buyer specified, the number comes from your supply agreement rather than a statute, which is why written product specifications matter as much as the regulatory floor. Two things in that table cause more rejections than the limits themselves. The first is method reference: an importing quality unit wants to see the pharmacopoeial chapter your laboratory worked to, not just the number it produced. The second is units. Australia's regulator expects heavy metals in mg/kg because parts per million can be read as either mg/kg or mg/L, and an ambiguous unit on a certificate of analysis is a question you will have to answer in writing.
Canada: the baseline every export batch starts from
Domestic compliance is where an export file begins. Under the Cannabis Act and its regulations, section 81 prohibits treating cannabis with a pest control product unless that product is registered or otherwise authorised under the Pest Control Products Act. Section 81.1 sets expectations for agronomic inputs, and section 94 caps chemical and microbial contaminants.
Health Canada layered mandatory pesticide testing on top of that. The requirements and the accompanying list and limits took effect on 2 January 2019, with an expanded list applying from 2 December 2019, and the list is reviewed periodically as laboratory capability and risk assessments change. Testing has to be performed under an analytical testing authorisation held under the Cannabis Act, and buyers routinely ask for ISO/IEC 17025 accreditation on top of that authorisation.
What Canadian records prove to an overseas buyer
Records tied to mandatory testing are held at the licensed site for two years, in addition to the record-keeping obligations already in the regulations. Health Canada also samples without notice during inspections, and those samples can include inputs such as soil, fertiliser and carrier oils rather than just finished lots.
That gives a Canadian certificate of analysis real evidentiary weight. It does not make it a passport. Nothing in the Canadian framework certifies that a lot meets a German monograph specification or an Australian assay window, which is exactly the gap importers ask you to close. Our guide to phytosanitary certificates covers the parallel plant health documentation that travels with the same shipment.
Where the specifications diverge: Germany, Australia and Israel
Germany and the EU: monograph compliance plus Qualified Person release
The Ph. Eur. cannabis flower monograph arrived in Supplement 11.5 in January 2024 and became official on 1 July 2024, replacing the national texts that importers previously worked to, including the German DAB monograph. Compared with the DAB version it tightened and loosened in different places. No seeds are permitted in the foreign matter test. Loss on drying rose to a maximum of 12% to reflect natural moisture variation in flower. Heavy metal limits were added. The cannabinoid content determination was rewritten for comparability between laboratories.
That text is already moving again. A revised monograph appeared in Pharmeuropa 37.4 with comments closing on 31 December 2025, widening the acceptance criteria for seeds and leaves and relaxing the thin layer chromatography identification criterion for THC dominant material. From the 12th edition the Ph. Eur. is published online only, in three issues a year rather than one edition plus eight supplements, so your quality unit needs a habit of version checking rather than an annual review.
Monograph conformity is only half of German market access. Batch certification by a Qualified Person is a statutory step under Directive 2001/83/EC, and Annex 16 of the EU GMP guide sets out what that person must verify before releasing third country material. Producers without their own EU site work through an importer holding a manufacturing and import authorisation, which typically means your results are reproduced by a European laboratory using monograph methods. German partners verify EU-GMP status in the EudraGMDP database before they commit, and BfArM is the federal authority behind the permit side of the transaction.
Australia: TGO 93 and where the liability sits
TGO 93 sets minimum quality requirements for medicinal cannabis supplied in Australia, and responsibility for conformance rests with the sponsor, not the overseas cultivator. Supplying goods that fail an applicable standard is an offence under the Therapeutic Goods Act 1989, which is why Australian sponsors negotiate specifications so hard.
Schedule 1 governs the plant material your batch comes from: aflatoxins, foreign matter at not more than 2.0%, heavy metals, ochratoxin A at not more than 20 ug/kg, pesticides to Ph. Eur. 2.8.13 and total ash at not more than 20.0%. Except for foreign matter, those limits apply on a dried basis. Finished herbal product then has to assay between 80% and 120% of the cannabinoid content stated on the label.
Two operational details matter more than they sound. Decontamination is permitted, and gamma irradiation is an accepted route to reduce microbial load provided product quality is not adversely affected, while ethylene oxide is ruled out. Reduced or rotational testing is possible where you can justify it under GMP, for example pesticides that are never used in cultivation, but the TGA has been increasing random and targeted testing, so the justification needs to survive an audit. Our irradiation guide and our Australian import compliance walkthrough go deeper on both.
Israel: IMC-GMP and the cultivation standard behind it
Israel's Medical Cannabis unit sets its test set through the IMC-GMP quality procedure, which builds on the Ph. Eur. general monograph for herbal drugs. Release testing covers the quantity and concentration of active substances, foreign matter, pesticides, heavy metals, microbial entities and toxins, and a batch that fails release testing cannot be distributed. On the cultivation side, imported material is expected to come from a facility working to IMC-GAP or a recognised good agricultural and collection practice equivalent, with GMP evidence supplied per product. Our note on supplying Israeli pharmaceutical distributors covers the commercial side of that relationship.
Building one release specification that travels
Maintaining four separate specifications and hoping the right one reaches the right lot is how mistakes happen. The practical answer is one internal release spec built to clear every destination at once. Call it the four market release spec. It comes down to five checks.
- Specify to the strictest limit in each family, not the average of your markets. One number per attribute is auditable. Four are not.
- Name the method beside the number. A limit without a pharmacopoeial chapter reference invites a re-test.
- Report in the units the destination expects, including mg/kg for Australian heavy metals.
- Settle decontamination policy before harvest, and disclose it. Irradiation is acceptable in some markets and unwelcome in some importer contracts.
- Version control the specification against the source texts: Ph. Eur. issues, updates to the Canadian pesticide list, and TGO revisions.
- Re-run the exercise before you add a market. The UK route adds its own overlay on top of the EU baseline.
The failures that strand a pallet are rarely exotic. A missing test the destination requires and Canada does not. A unit mismatch. Or a method the importing quality unit cannot map to a monograph chapter, on a certificate that reports pass or fail without the limit and method beside the result. Each one is a documentation problem wearing a quality problem's clothing, and each one is cheaper to fix before the pallet moves. Stability data is the other file importers ask for early, which our shelf life testing guide addresses.
AlphaLeaf grows indoor, hand-trimmed flower at its Montreal facility as a Health Canada Licensed Producer, with refined genetics, ISO/IEC 17025-tested batch data and lot level traceability behind every certificate of analysis. We hold export authorisation under the Cannabis Act and maintain the specification and documentation records that German, Australian and Israeli import partners work through before a first order.
If you are qualifying a Canadian supplier this quarter, talk to our quality team about the specification your market requires, or review our certifications and testing standards first.
Frequently Asked Questions
Does a Canadian certificate of analysis satisfy German import requirements?
Not on its own. Canadian testing under the Cannabis Regulations proves domestic compliance, but German market access also requires conformity with the European Pharmacopoeia cannabis flower monograph and batch certification by a Qualified Person working to Annex 16 of the EU GMP guide. In practice, an EU importer arranges confirmatory testing before release.
Which pharmacopoeia applies to cannabis flower exported to the EU?
The European Pharmacopoeia cannabis flower monograph, published in Supplement 11.5 in January 2024 and official from 1 July 2024. It replaced the national monographs previously used in Germany, Denmark, the Netherlands and Switzerland, and a revised version has already been through public consultation.
What cannabinoid assay tolerance does TGO 93 allow?
For herbal final form products, the measured cannabinoid content must fall between 80% and 120% of the content stated on the label. Plant material is separately governed by the Schedule 1 tests, and heavy metal results must be reported in mg/kg rather than parts per million.
Can gamma irradiation be used to meet microbial limits for export?
TGO 93 permits decontamination of cannabis plant material, including gamma irradiation to reduce microbial load, provided product quality is not adversely affected. Ethylene oxide is not permitted. Some importers and prescriber channels still ask for irradiation status to be disclosed, so treat it as a commercial question as well as a regulatory one.
Who is allowed to perform testing on a Canadian export batch?
Analytical testing must be carried out under an authorisation held for that activity under the Cannabis Act, and Health Canada publishes the list of authorised laboratories. International buyers commonly also require ISO/IEC 17025 accreditation for the specific methods on the certificate of analysis.
Which export market has the strictest cannabis testing requirements?
They are strict in different places. Australia sets the most explicit numeric limits inside the standard itself, so the specification is easy to read and hard to argue with. The EU is usually the harder operational gate, because monograph conformity is paired with Qualified Person certification and, in practice, confirmatory testing by a second laboratory after the shipment lands.
What testing does Israel require from an overseas supplier?
Release testing under the IMC-GMP quality procedure, which draws on the European Pharmacopoeia general monograph for herbal drugs and covers active substance content, foreign matter, pesticides, heavy metals, microbial entities and toxins. Material that fails release testing cannot be distributed, and cultivation is expected to meet IMC-GAP or an equivalent good agricultural and collection practice standard.
